Product
Intravitreal injection
2 clinical trials
4 indications
Indication
UveitisIndication
PanuveitisIndication
Macular EdemaIndication
Vascular OcclusionClinical trial
Sirolimus as a Therapeutic Approach for Uveitis: A Phase 2, Open-label, Randomized Study to Assess the Safety, Tolerability, and Bioactivity of Two Doses of Intravitreal Injection of Sirolimus in Patients With Non-infectious UveitisStatus: Withdrawn, Estimated PCD: 2024-09-01